<DOC>
	<DOCNO>NCT02328560</DOCNO>
	<brief_summary>The project aim primarily measure expect paramedic consultation announcement benefit patient , different level . It measure improvements management patient treat chemotherapy . Indeed , paramedical consultation ad aim provide good understanding disease treatment incur , lead implementation joint strategy healthcare team patient prevent effect treatment disease patient caregiver . This improvement promote fair treatment reduce patient anxiety / carers involve management disease . In context , show profit paramedical consultation patient , work , base recommendation Cancer Plan , strengthen need routinely offer paramedic Ad consultation . This work also help measure impact ad paramedical consultation optimize care consumption off-line therapy ass associate cost . For patient receive paramedic ad consultation , therefore particular compare intercurrent hospitalization , commute structure care , number consultation doctor , report cure , additional biological monitoring health care consumption . With participation several center fight cancer , study provide valuable information practice paramedical consultation ad several tumor site . It objectify benefit provide Medical device announcement patient organization use care prerequisite encourage well integration device course patient care , consultation paramedical ad remain poorly understood many health professional .</brief_summary>
	<brief_title>Impact Paramedic Announced Consultation Use Patient Care With Cancer Treated With Chemotherapy</brief_title>
	<detailed_description />
	<criteria>18 ≤ age &lt; 75 year ; WHO ≤ 1 ; Patients cancer candidate chemotherapy treatment first intention ; Solid lymphoid malignant disease pathology chemotherapy give intravenously ; Patient affiliate social security scheme ; Mastery French language ; Informed Consent sign ; In first cohort , patient receive paramedical consultation announcement day precede first cycle chemotherapy ; In second cohort , patient receive paramedical consultation announcement . Patient deprive liberty , guardianship ; Any medical psychological condition associate could compromise patient 's ability participate study ; Exclusive Oral Chemotherapy ; Exclusive Targeted therapy ; Targeted therapy introduce chemotherapy ; Presence cerebral localization ; Pain require analgesic bear 3 ; Patient medical social structure ; Inability submit medical monitoring test geographical , social psychological reason ; Rare Cancers make match difficult ( sarcomas soft tissue internal organ , malignant neuroendocrine tumor sporadic hereditary rare ... ) Inclusion another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>